Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SeizEAR Safety Study

NCT: NCT07088835 · RECRUITING

NCT IDNCT07088835
StatusRECRUITING
Start Date2025-05-08
Completion2026-12-31
SponsorIcahn School of Medicine at Mount Sinai (OTHER)
First posted
Last updated

Brief Summary

Determine the safety and feasibility of an in-ear device to measure seizures or suspected seizures compared to the standard scalp-based electroencephalogram (EEG). The study team anticipates enrolling five healthy participants through meeting announcements and a research email list serv in the Neurology Dept. Based on the appropriate positive initial test of healthy individuals, test the in-ear device on 10 participants with seizures or suspected seizures scheduled for a clinical scalp EEG test.

Frequently Asked Questions

What is SeizEAR Safety Study?

SeizEAR Safety Study is a clinical trial registered under NCT07088835. Current status: RECRUITING.

What is the status of NCT07088835?

The current status of NCT07088835 (SeizEAR Safety Study) is: RECRUITING.

When did SeizEAR Safety Study start?

SeizEAR Safety Study started on 2025-05-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.